-
公开(公告)号:US20090093497A1
公开(公告)日:2009-04-09
申请号:US12113222
申请日:2008-05-01
申请人: David Robert Bolin , Adrian Wai-Hing Cheung , Fariborz Firooznia , Matthew Micheal Hamilton , Lee Apostle McDermott , Yimin Qian , Jenny Tan , Weiya Yun
发明人: David Robert Bolin , Adrian Wai-Hing Cheung , Fariborz Firooznia , Matthew Micheal Hamilton , Lee Apostle McDermott , Yimin Qian , Jenny Tan , Weiya Yun
IPC分类号: A61K31/497 , C07D263/36 , A61K31/422 , A61K31/445 , C07D413/06 , C07D401/02
CPC分类号: C07D263/34 , C07D231/14 , C07D277/56 , C07D307/68 , C07D401/12 , C07D403/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/14
摘要: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
-
公开(公告)号:US07407977B2
公开(公告)日:2008-08-05
申请号:US11193766
申请日:2005-07-29
IPC分类号: A61K31/428 , C07D277/60 , C07D513/00
CPC分类号: C07D277/60 , C07D277/84 , C07D417/12 , C07D513/04
摘要: There are presented compounds of the formula or a pharmaceutically acceptable salt thereof, which are useful in the treatment of diabetes, diabetic retinopathy, asthma and diarrhea.
摘要翻译: 提供了可用于治疗糖尿病,糖尿病性视网膜病变,哮喘和腹泻的下式的化合物或其药学上可接受的盐。
-
公开(公告)号:US20070049616A1
公开(公告)日:2007-03-01
申请号:US11508445
申请日:2006-08-23
申请人: Gary Ksander , Erik Meredith , Lauren Monovich , Julien Papillon , Fariborz Firooznia , Qi-Ying Hu
发明人: Gary Ksander , Erik Meredith , Lauren Monovich , Julien Papillon , Fariborz Firooznia , Qi-Ying Hu
IPC分类号: A61K31/4745 , A61K31/4188 , C07D471/02
CPC分类号: C07D471/04 , A61K31/4188 , A61K31/437 , A61K31/454 , A61K31/5377 , A61K31/55 , A61K45/06 , C07D487/04
摘要: The present invention provides a compound of formula I: Said compound is inhibitor of aldosterone synthase and aromatase, and thus can be employed for the treatment of a disorder or disease mediated by aldosterone synthase or aromatase. Accordingly, the compound of formula I can be used in treatment of hypokalemia, hypertension, congestive heart failure, atrial fibrillation, renal failure, in particular, chronic renal failure, restenosis, atherosclerosis, syndrome X, obesity, nephropathy, post-myocardial infarction, coronary heart diseases, inflammation, increased formation of collagen, fibrosis such as cardiac or myocardiac fibrosis and remodeling following hypertension and endothelial dysfunction, gynecomastia, osteoporosis, prostate cancer, endometriosis, uterine fibroids, dysfunctional uterine bleeding, endometrial hyperplasia, polycystic ovarian disease, infertility, fibrocystic breast disease, breast cancer and fibrocystic mastopathy. Finally, the present invention also provides a pharmaceutical composition.
摘要翻译: 本发明提供式I化合物:所述化合物是醛固酮合成酶和芳香酶的抑制剂,因此可用于治疗由醛固酮合成酶或芳香酶介导的病症或疾病。 因此,式I化合物可用于治疗低钾血症,高血压,充血性心力衰竭,心房颤动,肾衰竭,特别是慢性肾衰竭,再狭窄,动脉粥样硬化,综合征X,肥胖症,肾病,心肌梗塞后, 冠状动脉心脏病,炎症,胶原蛋白形成增加,纤维化如心脏或心肌纤维化,以及高血压和内皮功能障碍后重塑,男子乳腺发育不良,骨质疏松症,前列腺癌,子宫内膜异位症,子宫肌瘤,功能障碍性子宫出血,子宫内膜增生,多囊卵巢疾病,不育症 ,纤维囊性乳腺疾病,乳腺癌和纤维囊性乳腺病。 最后,本发明还提供药物组合物。
-
公开(公告)号:US20060030589A1
公开(公告)日:2006-02-09
申请号:US11193766
申请日:2005-07-29
申请人: Jianping Cai , Adrian Cheung , Fariborz Firooznia , Kevin Guertin , Lida Qi
发明人: Jianping Cai , Adrian Cheung , Fariborz Firooznia , Kevin Guertin , Lida Qi
IPC分类号: A61K31/454 , A61K31/4439 , A61K31/428 , C07D417/02 , C07D277/84
CPC分类号: C07D277/60 , C07D277/84 , C07D417/12 , C07D513/04
摘要: There are presented compounds of the formula or a pharmaceutically acceptable salt thereof, which are useful in the treatment of diabetes, diabetic retinopathy, asthma and diarrhea.
摘要翻译: 提供了可用于治疗糖尿病,糖尿病性视网膜病变,哮喘和腹泻的下式的化合物或其药学上可接受的盐。
-
公开(公告)号:US06613782B2
公开(公告)日:2003-09-02
申请号:US10080798
申请日:2002-02-21
申请人: Stéphane De Lombaert , Cynthia Anne Fink , Fariborz Firooznia , Denton Wade Hoyer , Arco Yingcheu Jeng
发明人: Stéphane De Lombaert , Cynthia Anne Fink , Fariborz Firooznia , Denton Wade Hoyer , Arco Yingcheu Jeng
IPC分类号: A01N4340
CPC分类号: C07D239/26 , A61K31/165 , A61K31/44 , A61K31/47 , C07D209/20 , C07D213/56 , C07D307/54 , C07D307/81 , C07D333/24 , C07D333/60
摘要: Disclosed as endothelin converting enzyme inhibitors are the compounds of the formula wherein the variables have the meanings as defined hereinbefore.
-
-
-
-